Related Experiment Video
Updated: May 27, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used
Eleanor M Pullenayegum1,2, Jean-Eric Tarride1,3, Feng Xie1,3
1Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada (EMP, J-ET, FX, DO)
Background:
When calculating the decreases in health utility associated with adverse events, often a number of respondents achieve the upper utility bound of 1. "Marginal" Tobit or CLAD coefficients have been used to account for this. These are calculated by using a Tobit or a CLAD model to estimate the decrease in a latent unbounded variable associated with the event or condition, then to multiply by the proportion of respondents falling below 1 in order to transform back to the utility scale.
Objective:
&
Methods:
Starting with the Tobit model, we show mathematically that this procedure is not valid, when calculating decreases in utility associated with binary events. We then generalize the result to the CLAD model. A selection of published studies is used to illustrate the bias in the marginal Tobit decrements.
Results:
The degree of bias is more severe the greater the decrease in utility associated with the event, and the larger the proportion of individuals at the upper ceiling.In the examples studied, the degree of bias was often greater than 10%. We provide the correct formula for calculating the utility decrement.
Conclusions:
The marginal Tobit and CLAD coefficients should not be used as estimates of a utility decrement corresponding to an adverse event or health condition unless the coefficients are small in absolute value, or if the proportion of individuals at the upper utility bound is small. In other settings, the corrected formula or alternative regression methods (e.g. linear models of mean utility) should be considered.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assumptions of Survival Analysis
Kaplan-Meier Approach
The Mantel-Cox Log-Rank Test
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Hazard Rate

